Trial · NCT02430077
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the Liver Triglycerides (TG). | Baseline (Month 0) | 13.2 | Full Range 2.8 to 28.5 | percentage of liver triglycerides | |
| Change in the Liver Triglycerides (TG). | Obeticholic Acid (Month 4) | 6.4 | Full Range 2.4 to 18.0 | percentage of liver triglycerides | |
| Change in the Liver Triglycerides (TG). | Placebo (Month 0) | 12.3 | Full Range 3.6 to 33.3 | percentage of liver triglycerides | |
| Change in the Liver Triglycerides (TG). | Placebo (Month 4) | 10.6 | Full Range 3.4 to 29.3 | percentage of liver triglycerides | |
| Change in Serum Triglyceride Levels | Baseline (Month 0) | 199.2 | Full Range 78 to 392 | mg/dL | |
| Change in Serum Triglyceride Levels | Obeticholic Acid (Month 4) | 182.3 | Full Range 102 to 309.3 | mg/dL | |
| Change in Serum Triglyceride Levels | Placebo (Month 0) | 169.3 | Full Range 103.5 to 562.0 | mg/dL | |
| Change in Serum Triglyceride Levels | Placebo (Month 4) | 161.3 | Full Range 93 to 655 | mg/dL | |
| Change in Serum Levels of Alanine Aminotransferase | Baseline (Month 0) | 16.3 | Full Range 13.5 to 31 | U/L | |
| Change in Serum Levels of Alanine Aminotransferase | Obeticholic Acid (Month 4) | 15.8 | Full Range 13 to 42.5 | U/L | |
| Change in Serum Levels of Alanine Aminotransferase | Placebo (Month 0) | 19.0 | Full Range 11 to 33.5 | U/L | |
| Change in Serum Levels of Alanine Aminotransferase | Placebo (Month 4) | 18.5 | Full Range 12.6 to 33 | U/L | |
| Change in Serum Levels of Aspartate Aminotransferases | Baseline (Month 0) | 15.5 | Full Range 13.5 to 35.5 | U/L | |
| Change in Serum Levels of Aspartate Aminotransferases | Obeticholic Acid (Month 4) | 16.8 | Full Range 13.7 to 27 | U/L | |
| Change in Serum Levels of Aspartate Aminotransferases | Placebo (Month 0) | 18.7 | Full Range 13.5 to 28.5 | U/L | |
| Change in Serum Levels of Aspartate Aminotransferases | Placebo (Month 4) | 16.5 | Full Range 12.5 to 31 | U/L | |
| Change in Serum Levels of Gamma-Glutamyl Transpeptidase | Baseline (Month 0) | 27.5 | Full Range 16.3 to 64 | U/L | |
| Change in Serum Levels of Gamma-Glutamyl Transpeptidase | Obeticholic Acid (Month 4) | 17 | Full Range 10.6 to 45.7 | U/L | |
| Change in Serum Levels of Gamma-Glutamyl Transpeptidase | Placebo (Month 0) | 21.6 | Full Range 14.6 to 109 | U/L | |
| Change in Serum Levels of Gamma-Glutamyl Transpeptidase | Placebo (Month 4) | 21.2 | Full Range 13.5 to 66 | U/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02430077/results